Use of a Subcutaneous Catheter for Controlled Ovarian Stimulation

Description

Subcutaneous medications are an integral part of controlled ovarian stimulation protocols for in-vitro fertilization (IVF), but daily or twice daily injections are both physically and emotionally burdensome for patients and their partners. This is a feasibility study to evaluate the use of the Neria Guard™ (Unomedical, Convatec) subcutaneous catheter for ovarian stimulation in IVF.

Conditions

Infertility, Female

Study Overview

Study Details

Study overview

Subcutaneous medications are an integral part of controlled ovarian stimulation protocols for in-vitro fertilization (IVF), but daily or twice daily injections are both physically and emotionally burdensome for patients and their partners. This is a feasibility study to evaluate the use of the Neria Guard™ (Unomedical, Convatec) subcutaneous catheter for ovarian stimulation in IVF.

Use of a Subcutaneous Catheter for Controlled Ovarian Stimulation

Use of a Subcutaneous Catheter for Controlled Ovarian Stimulation

Condition
Infertility, Female
Intervention / Treatment

-

Contacts and Locations

Los Angeles

HRC Fertility, Los Angeles, California, United States, 91101

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * Female between 18 and 45 years of age undergoing controlled ovarian stimulation
  • * none

Ages Eligible for Study

18 Years to 45 Years

Sexes Eligible for Study

FEMALE

Accepts Healthy Volunteers

Yes

Collaborators and Investigators

University of Southern California,

Richard J Paulson, MD, PRINCIPAL_INVESTIGATOR, University of Southern California

Study Record Dates

2024-12-31